Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets

Author(s):  Rice Stephen P

Issue:  Mar/Apr 2002 - Dermatologic Compounding
View All Articles in Issue

Page(s):  120-122

A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Page 1
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Page 2
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Page 3

Download in electronic PDF format for $75

Abstract:  In this article, the authors list medications available in the United States that require specific containers and/or administration sets. One table includes medications that sorb to polyvinyl chloride containers and tubing; another lists medications that leach the plasticizer diethylhexyl phthalate from diethylhexyl phthalate-plasticized polyvinyl chloride bags and/or tubing to an extent that exceeds the target range of 20 micrograms/kilogram/day. The authors conclude that pharmacists practicing in a demanding intravenous admixture setting should review medication preparation guidelines for suitable diluents, volumes required for reconstitution, compatible solutions, final admixture volumes and rates of infusion. As new parenteral drug entities are introduced into the marketplace, pharmacists must select the most suitable infusion containers to provide optimal and safe parenteral therapy.

Related Keywords: Parenteral admixtures, percent of drugs sorbed to containers

Related Categories: INFUSION, PARENTERALS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
Mar/Apr 2002
Pg. 120-122

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Parenteral Admixture with Y-Site Administration
Allen Loyd V Jr
Jul/Aug 1999
Pg. 303

How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A
, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019
Pg. 454-461

Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Desai Narendra R
, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Sep/Oct 2007
Pg. 426-432

Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan
, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021
Pg. 52-61

Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E
, Aclan Jennifer, Szatkowski Aaron
Sep/Oct 2008
Pg. 463-466

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
May/Jun 2022
Pg. 219-228

Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402

Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures
Fausel Christopher A
, Newton David W, Driscoll David F, Allen Loyd V Jr
Jan/Feb 1997
Pg. 54-59

Parenteral Admixture Incompatibilities:An Introduction
Allen Loyd V Jr
May/Jun 1997
Pg. 165-167

Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions
Martinez Juan F
, Trissel Lawrence A, Gilbert Doward L Jr
Sep/Oct 1997
Pg. 356-358

Autoclaves for the Sterilization of Compounded Parenteral Products
Rahe Hank
Mar/Apr 2003
Pg. 114-116

How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R
, Radwick Allison
Jan/Feb 2020
Pg. 14-19

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Return to Top